New drug cocktail tested for tough stomach cancers
NCT ID NCT07311408
Summary
This study is testing two different drug combinations for people with advanced stomach or gastroesophageal junction cancer whose disease has continued to grow despite receiving first-line immunotherapy. Researchers want to see if adding a third drug to a two-drug combination is more effective at controlling the cancer. The study will measure how long patients live without their cancer getting worse and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Liaoning Provincial Cancer Hospital
RECRUITINGShenyang, Liaoning, 11000, China
Conditions
Explore the condition pages connected to this study.